CaMKK2 in Central Nervous System Disorders: Context-Dependent Signaling and Therapeutic Challenges
Cells · 05.11.2026 · 15 (21) · 2012
DOI: 10.3390/cells15212012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 05.11.2026. Verfasst von Jia-Xi Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Biomedical Engineering, South-Central Minzu University, Wuhan 430074, China. Hauptthemen laut MEDLINE: Calcium-Calmodulin-Dependent Protein Kinase Kinase, Central Nervous System Diseases, Signal Transduction. Die Arbeit nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, South-Central Minzu University.
Abstract (Originalsprache)
Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) couples calcium signaling to metabolic, inflammatory, and transcriptional pathways and has been implicated in a broad range of central nervous system (CNS) disorders. However, its effects vary across disease settings, and the mechanisms underlying this context dependence remain poorly defined. This narrative review examines genetic, transcriptomic, biochemical, cellular, and in vivo evidence on the roles of CaMKK2 across CNS disorders, with emphasis on signaling pathways, cell type-specific functions, and implications for therapeutic targeting. CaMKK2-associated pathways influence neurovascular responses, synaptic function, protein homeostasis, inflammation, and tumor progression through signaling networks involving AMPK, CaMK1, CaMK4, and Akt. CaMKK2 can exert distinct, and in some settings opposing, effects depending on cell type, downstream pathway engagement, intervention timing, and pathological context. Pharmacological studies remain limited by incomplete selectivity, insufficient characterization of CNS pharmacokinetics, and context-dependent biological effects. Moreover, much of the mechanistic evidence derives from experimental models, and validated biomarkers for clinical translation remain limited. Overall, CaMKK2 emerges as a context-dependent signaling node linking calcium signaling to metabolic and inflammatory pathways in CNS disorders, with therapeutic potential but substantial challenges for therapeutic translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biomedical Engineering, South-Central Minzu University, Wuhan 430074, China.
- Ting Tsung and Wei Fong Chao Center for BRAIN, Houston Methodist Academic Institute and Weill Cornell Medicine, Houston, TX 77030, USA.
- Hubei Key Laboratory of Medical Information Analysis & Tumor Diagnosis and Treatment, Wuhan 430074, China.
- Key Laboratory of Cognitive Science, State Ethnic Affairs Commission, Wuhan 430074, China.
ORCID-Profile: Jia-Wei Min
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities, South-Central Minzu University
Zitieren
APA
Zhang, J. X., Zou, Y. K., Lin, X. G., Qi, S. H., & Min, J. W. (2026). CaMKK2 in Central Nervous System Disorders: Context-Dependent Signaling and Therapeutic Challenges. Cells, 15(21), 2012. https://doi.org/10.3390/cells15212012
Vancouver
Zhang JX, Zou YK, Lin XG, Qi SH, Min JW. CaMKK2 in Central Nervous System Disorders: Context-Dependent Signaling and Therapeutic Challenges. Cells. 2026;15(21):2012. doi:10.3390/cells15212012
BibTeX
@article{Zhang2026,
author = {Zhang, Jia-Xi and Zou, Yi-Kai and Lin, Xian-Guang and Qi, Shao-Hua and Min, Jia-Wei},
title = {CaMKK2 in Central Nervous System Disorders: Context-Dependent Signaling and Therapeutic Challenges},
journal = {Cells},
year = {2026},
volume = {15},
number = {21},
pages = {2012},
doi = {10.3390/cells15212012}
}
EUVIMED